Triple-Negative Receptor Conversion at Metastatic Sites Might Show Better Efficacy in Patients Who Received Sacituzumab Govitecan.

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)

Keyphrases